iifl-logo

Elder Pharmaceuticals Ltd Share Price

38
(4.97%)
Sep 12, 2016|03:28:30 PM

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Elder Pharmaceuticals Ltd KEY RATIOS

Sector

Pharmaceuticals

Open

38

Prev. Close

36.2

Turnover(Lac.)

1.74

Day's High

38

Day's Low

38

52 Week's High

0

52 Week's Low

0

Book Value

382.46

Face Value

10

Mkt Cap (₹ Cr.)

78.05

P/E

0

EPS

0

Divi. Yield

0

Elder Pharmaceuticals Ltd Corporate Action

No Record Found

Elder Pharmaceuticals Ltd NEWS AND UPDATE

No Record Found

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Elder Pharmaceuticals Ltd SHAREHOLDING SNAPSHOT

01 Apr, 2025|05:24 AM
  • Foreign Promoter
  • Indian Promoter
  • Institutions
  • Non Institutions
  • Custodies

Promoter- 25.34%

Foreign: 0.00%

Indian: 25.34%

Non-Promoter- 23.98%

Institutions: 23.98%

Non-Institutions: 50.67%

Custodian: 0.00%

Share Price

Elder Pharmaceuticals Ltd FINANCIALS

Balance Sheet

Profit & Loss

Cash Flow

Ratios

Results

Y/e 31 Mar( In .Cr)Jun-2014Jun-2013Mar-2012Mar-2011

Equity Capital

20.57

20.57

20.57

20.57

Preference Capital

0

0

0

0

Reserves

765.03

757.26

671.19

590.55

Net Worth

785.6

777.83

691.76

611.12

Minority Interest

View Balance Sheet
Y/e 31 Mar( In .Cr)Jun-2014Jun-2013Mar-2012

Revenue

483.47

1,233.09

984.68

yoy growth (%)

-60.79

25.22

Raw materials

-308.35

-573.09

-471.35

As % of sales

63.77

46.47

47.86

Employee costs

-112.38

-151.43

-108.97

View Profit & Loss
Y/e 31 Mar( In .Cr)Jun-2014Jun-2013Mar-2012

Profit before tax

-362.19

120.79

109.8

Depreciation

-29.15

-36.52

-27.63

Tax paid

-9.93

-21.96

-19.43

Working capital

-239.12

-156.42

Other operating items

View Cash Flow
Y/e 31 MarJun-2014Jun-2013Mar-2012

Growth matrix (%)

Revenue growth

-60.79

25.22

Op profit growth

-132.74

33.09

EBIT growth

-139.46

30.14

Net profit growth

-91.54

11.49

View Ratios
Particulars (Rupees in Crores.)Jun-2014Jun-2013Mar-2013Mar-2012Mar-2011

Gross Sales

1,006.13

1,638.53

1,454.28

1,332.32

964.28

Excise Duty

0

0

0

0

0

Net Sales

1,006.13

1,638.53

1,454.28

1,332.32

964.28

Other Operating Income

2.76

3.17

2.34

2.45

1

Other Income

396.92

32.7

30.59

28.04

8.65

Elder Pharmaceuticals Ltd Peer Comparison

Company Name
LTP
(₹)
P/E
(%)
Mkt.Cap
(₹Cr.)
NP Qtr
(₹Cr.)
Div.Yield
(%)
Sales Qtr
(₹.Cr)
Book Value
(₹)

Sun Pharmaceutical Industries Ltd

SUNPHARMA

1,698.35

129.244,07,155.151,181.050.85,985.3398.33

Divis Laboratories Ltd

DIVISLAB

5,549.7

73.931,53,257.675940.522,297513.62

Cipla Ltd

CIPLA

1,444.25

25.071,16,664.331,438.150.94,134.87360.73

Torrent Pharmaceuticals Ltd

TORNTPHARM

3,183.9

59.031,07,673.274850.882,330222.38

Mankind Pharma Ltd

MANKIND

2,458.1

51.799,973.97416.3802,396.57334.17

Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.

MORE ABOUT Elder Pharmaceuticals Ltd

Management

Register Office

Registrar Office

Managing Director & CEO

Alok Jagdish Saxena

Director

Edoardo Carlo Richter

Company Secretary

Vijendra Jain

Additional Director

Ravani Mohammed Abdul Khader

Additional Director

Kader Mohammed Davawala

Registered Office


Tel: -

Website: -

Email: -

Registrar Office


Tel: -

Website: -

Email: -

Summary

Elder Pharmaceuticals Ltd is one of the fastest growing pharmaceutical companies in India. The companys principal activities include the manufacturing and marketing of prescription pharmaceutical brands, surgical and medical devices. They are engaged in the manufacture of a wide range of pharmaceutical product through research and development and also in the manufacturing and marketing of diverse products through licensing agreements with international pharmaceutical companies. They are also engaged in the manufacturing of active pharmaceutical ingredients. Elder Pharmaceuticals Ltd was incorporated on April 2, 1983 in Maharashtra. The company started their commercial activities in the year 1988. In the year 1989, they commissioned their first factory in Navi Mumbai. The company was converted into a public limited company in August 1998. Over the years, the company launched the medicines either through their own research or through alliances with global companies.The company entered into strategic alliances with a number of international pharmaceutical entities for marketing their products in India and overseas international acquisitions have strengthened and enabled the company to become a true-global pharmaceutical company. They made the tie up with Haw Par, Singapore during the year 1994 and Fujisawa during the year 1998.During the year 2000-01, the company entered into joint venture agreement with Stiefel Laboratories Inc. Also they made a tie up with Paul Hartmann of Ger
Read More

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2025, IIFL Capital Services Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Securities Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248

ISO certification icon
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.